INFLAMMATION ROLE AND ANTI-INFLAMMATORY STRATEGIES IN ACUTE CARDIOVASCULAR PATHOLOGY

INFLAMMATION ROLE AND ANTI-INFLAMMATORY STRATEGIES IN ACUTE CARDIOVASCULAR PATHOLOGY

In patients with myocardial infarction, the dynamics of acute phase proteins (APP), oxidative stress and white blood cell functional activity was investigated. A statistically significant increase in APP levels was observed starting from Day 1, reached its peak at Day 7, and disappeared by Day 28. A...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. I. Chukaeva, N. V. Orlova, F. A. Evdokimov, V. A. Aleshkin, O. O. Soloshenkova, L. I. Novikova, N. P. Rechnova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2009-10-01
Series:	Российский кардиологический журнал
Subjects:	myocardial infarction prognosis inflammation acute phase proteins oxidative stress ace inhibitors
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1383
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CYTOKINE ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: I. I. Chukaeva, et al.
Published: (2010-08-01)

ANGIOTENSIN II AND MYOCARDIAL INFARCTION
by: O. P. Shevchenko, et al.
Published: (2016-01-01)

Pro-inflammatory cytokines and depression in myocardial infarction
by: O. L. Barbarash, et al.
Published: (2011-04-01)

Prediction of recurrent myocardial infarction in working-age patients
by: E. A. Shishkina, et al.
Published: (2020-09-01)

Prognosing of myocardial infarction outcome in arterial hypertension patients
by: V. N. Ardashev, et al.
Published: (2004-04-01)

FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY
by: O. G. Zaylobidinov, et al.
Published: (2016-01-01)

ENDOTHELINES AND CARDIOVASCULAR PATHOLOGY
by: A. M. Alieva, et al.
Published: (2014-11-01)

Comorbidity in acute heart failure complicating myocardial infarction
by: M. V. Zykov, et al.
Published: (2020-08-01)

THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER)
by: M. L. Ginzburg, et al.
Published: (2015-09-01)

CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP)
by: V. A. Shulman, et al.
Published: (2015-12-01)

EFFECT OF ACE INHIBITOR AND RECEPTOR ANTAGONIST OF TYPE 1 ANGIOTENSIN II ON HEMODYNAMICS AND MORPHO-FUNCTIONAL PARAMETERS OF THE HEART IN PATIENTS WITH HEART FAILURE ON A BACKGROUND OF CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES
by: Z. V. BITAROVA, et al.
Published: (2017-09-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders
by: B. U. Mardanov, et al.
Published: (2015-11-01)

Annual personalised calculator for prognostication after ST-segment elevation myocardial infarction
by: V. B. Barbarich, et al.
Published: (2020-06-01)

Clinical and psychological factors affecting sudden death risk in myocardial infarction patients
by: S. A. Boldueva, et al.
Published: (1970-01-01)

THE INFLUENCE OF GLYCEMIA ON SHORT-TERM PROGNOSIS IN MYOCARDIAL INFARCTION WITHOUT ANAMNESIS OF 2ND TYPE DIABETES
by: K. K. Kholmatova, et al.
Published: (2014-04-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

RETROSPECTIVE ANALYSIS OF MYOCARDIAL RUPTURE CASES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: L. E. Rudakova, et al.
Published: (2010-08-01)

THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01)

ACE inhibitors: new perspectives in cardiovascular disease treatment
by: V. I. Makolkin
Published: (2005-10-01)

IMPORTANCE OF CARDIAC AND PULMONARY HEMODYNAMICAL VALUES IN VARIOUS PERIODS OF MYOCARDIAL INFARCTION FOR EARLY DIAGNOSING POSTINFARCTIONAL HEART REMODELING
by: N. I. Tarasov, et al.
Published: (2001-02-01)

ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE
by: M. V. Solodun, et al.
Published: (2015-09-01)

PERSISTENT ST SEGMENT ELEVATION/DEPRESSION IN MYOCARDIAL INFARCTION PATIENTS AND ITS VALUE IN PREDICTING SHORT-TERM POST-HOSPITAL OUTCOMES
by: S. V. Semakina, et al.
Published: (2010-06-01)

Effect of levosimendan on long-term prognosis in patients with myocardial infarction and concomitant chronic brain ischemia
by: N. B. Lebedeva, et al.
Published: (2021-02-01)

IMPACT OF ATRIAL FIBRILLATION ON THE NEAR AND LONG-TERM PROGNOSIS OF LIFE AFTER ACUTE MYOCARDIAL INFARCTION. THE DATA OF THE LIS-1 STUDY (LYUBERTSY MORTALITY STUDY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

MYCOPLASMA SPP. INFECTIONS AND MYOCARDIAL INFARCTION
by: I. P. Arleyevsky, et al.
Published: (2003-08-01)

PROGNOSTIC VALUE OF PATHOLOGIC Q-WAVE AND TIME OF ITS APPEARANCE IN PATIENTS WITH MYOCARDIAL INFARCTION: COMPARISON STUDY
by: V. A. Shulman, et al.
Published: (2016-01-01)

CONSERVATIVE THERAPY IN MYOCARDIAL INFARCTION: THE IMPACT OF GENETIC FACTORS
by: M. V. Solodun
Published: (2016-03-01)

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
by: I. A. Skripnikova, et al.
Published: (2015-12-01)

INFLAMMATORY REACTIONS IN EXPERIMENTAL MYOCARDIAL DAMAGE
by: L. D. Khidirova, et al.
Published: (2015-12-01)

Matrix metalloprotease 9 and remodeling after myocardial infarction
by: M. G. Shurygin, et al.
Published: (2013-04-01)

CLINICAL CASE OF THROMBOLYTIC THERAPY OF RECURRENT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENT WITH LONG HISTORY OF ISCHEMIC HEART DISEASE
by: N. T. Vatutin, et al.
Published: (2016-06-01)

Prognostic value of elevated transaminase levels as predictors of adverse outcomes in patients with acute myocardial infarction
by: T. H. Hoang, et al.
Published: (2024-10-01)

Refractory post-infarction myocardial ischemia: treatment potential
by: V. V. Ryabov, et al.
Published: (2011-08-01)

Prediction of in-hospital mortality in patients with myocardial infarction and type 2 diabetes: the role of cellular indices of systemic inflammation
by: I. F. Bokovikov, et al.
Published: (2024-08-01)

THE PROGNOSTIC IMPORTANCE OF RISK FACTORS AND MEDICAL HISTORY DATA ON THE MORTALITY OF PATIENTS OF STABLE ANGINA AT 5 YEARS PROSPECTIVE STUDY (FRAGMENT OF THE REGISTER ACS/AMI
by: R. S. Mamutov, et al.
Published: (2017-03-01)

PREDICTIVE VALUE OF ECHOCARDIOGRAPHY IN POST MYOCARDIAL INFARCTION SETTING. PART 1
by: P. V. Krikunov, et al.
Published: (2017-12-01)

PREDICTIVE VALUE OF ECHOCARDIOGRAPHY IN POST MYOCARDIAL INFARCTION SETTING. PART 2
by: P. V. Krikunov, et al.
Published: (2018-03-01)

RELATION OF THE MARKERS OF MYOCARDIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION WITH STRUCTURAL AND FUNCTIONAL PARAMETERS OF THE LUNGS IN MYOCARDIAL INFARCTION PATIENTS
by: O. M. Polikutina, et al.
Published: (2018-04-01)

HIGH PREVALENCE OF ANXIETY AND 15-YEAR CARDIOVASCULAR RISK IN RUSSIA/SIBERIA INHABITANTS (WHO FRAMEWORK “MONICA-PSYCHOSOCIAL”)
by: V. V. Gafarov, et al.
Published: (2017-02-01)